175 results on '"Tai, Andrew W."'
Search Results
2. Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis
3. Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection
4. Self-Assembled STING-Activating Coordination Nanoparticles for Cancer Immunotherapy and Vaccine Applications.
5. How to effectively engage with preclinical medical learners
6. Cytoplasmic Dynein Regulation by Subunit Heterogeneity and Its Role in Apical Transport
7. A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus
8. Reticulons promote formation of ER-derived double-membrane vesicles that facilitate SARS-CoV-2 replication
9. Type I interferon signaling induces a delayed antiproliferative response in Calu-3 cells during SARS-CoV-2 infection
10. Correction: Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis
11. Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis
12. A specific EMC subunit supports Dengue virus infection by promoting virus membrane fusion essential for cytosolic genome delivery
13. Treating hepatitis C infection by targeting the host
14. SARS-CoV-2 remodels the Golgi apparatus to facilitate viral assembly and secretion
15. Identification of cell type specific ACE2 modifiers by CRISPR screening
16. Chronic hepatitis C
17. Chronic hepatitis C
18. Measuring Activity of Phosphoinositide Lipid Kinases Using a Bioluminescent ADP-Detecting Assay
19. Hepatitis C Virus Infection
20. Racial Differences in Response to Interferon-Based Antiviral Therapy for Hepatitis C Virus Infection: A Hardwiring Issue?
21. Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures
22. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies
23. A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine
24. Oral simethicone tablets with PEG‐ELS split‐prep reduces frequency of inadequate bowel cleansing and decreases bubbles
25. Identification of ACE2 modifiers by CRISPR screening
26. IgV somatic mutation of human anti–SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity
27. An interferon-free, all-oral regimen is effective in treatment of genotype 1 chronic HCV infection
28. What faculty write versus what students see? Perspectives on multiple-choice questions using Bloom’s taxonomy
29. Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures
30. Rab18 supports hepatitis C virus assembly/secretion by enhancing viral NS5A recruitment to cellular lipid droplets: 57
31. Nivolumab-induced large-duct cholangiopathy treated with ursodeoxycholic acid and tocilizumab
32. Nir2 Is an Effector of VAPs Necessary for Efficient Hepatitis C Virus Replication and Phosphatidylinositol 4-Phosphate Enrichment at the Viral Replication Organelle
33. Rhodopsin Trafficking and its Role in Retinal Dystrophies
34. The ER Membrane Protein Complex Promotes Biogenesis of Dengue and Zika Virus Non-structural Multi-pass Transmembrane Proteins to Support Infection
35. Nir2 Is an Effector of VAPs Necessary for Efficient Hepatitis C Virus Replication and Phosphatidylinositol 4-Phosphate Enrichment at the Viral Replication Organelle.
36. Functional Analysis of the Dengue Virus Genome Using an Insertional Mutagenesis Screen
37. Dengue Virus Hijacks a Noncanonical Oxidoreductase Function of a Cellular Oligosaccharyltransferase Complex
38. Continuous de novo generation of spatially segregated hepatitis C virus replication organelles revealed by pulse-chase imaging
39. Competitive Inhibition of the Endoplasmic Reticulum Signal Peptidase by Non-cleavable Mutant Preprotein Cargos
40. Oxysterol-Binding Protein Is a Phosphatidylinositol 4-Kinase Effector Required for HCV Replication Membrane Integrity and Cholesterol Trafficking
41. Discovery of Potent Broad Spectrum Antivirals Derived from Marine Actinobacteria
42. An interferon-free, all-oral regimen is effective in treatment of genotype 1 chronic HCV infection
43. Rab18 Binds to Hepatitis C Virus NS5A and Promotes Interaction between Sites of Viral Replication and Lipid Droplets
44. HBV core promoter mutations promote cellular proliferation through E2F1-mediated upregulation of S-phase kinase-associated protein 2 transcription
45. A functional genomic screen reveals novel host genes that mediate interferon-alpha’s effects against hepatitis C virus
46. The Role of the Phosphatidylinositol 4-Kinase PI4KA in Hepatitis C Virus-Induced Host Membrane Rearrangement
47. A homogeneous and nonisotopic assay for phosphatidylinositol 4-kinases
48. Hepatitis B Virus Core Promoter Mutations Contribute to Hepatocarcinogenesis by Deregulating SKP2 and Its Target, p21
49. Genetic and functional studies of phosphatidyl-inositol 4-kinase type IIIα
50. Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.